|
| Status |
Public on Jul 27, 2017 |
| Title |
Ribosome profiling of MCF10A cells treated with TGFb and esterified leucine |
| Organism |
Homo sapiens |
| Experiment type |
Other
|
| Summary |
MCF10A-inducible RASV12 cells were treated with TGF-beta for 48hr. As rescue experiment, in one sample cells were treated with esterified leucine for 18hr.
|
| |
|
| Overall design |
1 replicate per condition
|
| |
|
| Contributor(s) |
Loayza-Puch F, Rooijers K, Zijlstra J, Oude Vrielink JF, Lopes R, Ugalde AP, Bex A, Agami R |
| Citation(s) |
28274951 |
| Submission date |
Jun 16, 2015 |
| Last update date |
Mar 19, 2021 |
| Contact name |
Koos Rooijers |
| E-mail(s) |
k.rooijers@nki.nl
|
| Organization name |
Netherlands Cancer Institute
|
| Department |
Gene Regulation
|
| Lab |
Agami Lab
|
| Street address |
Plesmanlaan 121
|
| City |
Amsterdam |
| ZIP/Postal code |
1066CX |
| Country |
Netherlands |
| |
|
| Platforms (1) |
| GPL16791 |
Illumina HiSeq 2500 (Homo sapiens) |
|
| Samples (3) |
|
| This SubSeries is part of SuperSeries: |
| GSE74509 |
Ribosome profiling of TGFb-treated cells indicates reduced leucine availability |
|
| Relations |
| BioProject |
PRJNA287138 |
| SRA |
SRP059547 |
